280
Participants
Start Date
January 31, 2015
Primary Completion Date
April 30, 2027
Study Completion Date
December 31, 2028
Extracorporeal Photopheresis (ECP)
"Procedure:~ECP treatments will be performed using one of two Therakos systems. Both systems use the drug Methoxsalen"
No intervention in the SOC / Retrospective Chart review.
SOC Retrospective chart review similar to a control group
Columbia University, New York
University of Pittsburgh, Pittsburgh
Temple University, Philadelphia
Inova Health System, Falls Church
Duke University, Durham
University of Florida, Gainesville
University of Alabama at Birmingham, Birmingham
University of Kentucky, Lexington
Ohio State University, Columbus
Spectrum Health, Grand Rapids
Indiana University Health, Indianapolis
University of Michigan Health System, Ann Arbor
University of Iowa, Iowa City
University of Minnesota Medical Center, Fairview, Minneapolis
Northwestern University, Chicago
Washington University School of Medicine, St Louis
Baylor University Medical Center, Dallas
UT Southwestern Medical Center, Dallas
Houston Methodist, Houston
St. Joseph's Hospital and Medical Center, Phoenix
University of California San Diego, La Jolla
Brigham and Women's Hospital, Boston
Centers for Medicare and Medicaid Services/ Coverage and Analysis Group
FED
Therakos, Inc
UNKNOWN
The Foundation for Barnes-Jewish Hospital
OTHER
Washington University School of Medicine
OTHER